Chemed Corp (CHE) stock

CHENYSEServices-Home Health Care ServicesFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 17/305% above fair value

$550.20−0.42 (-0.08%)

Close on Nov 12, 2026Market cap $7.16BP/E 26.3Yield 0.40%

Chemed r&d expenses

Research and development expenses are spending on new products and technology.

Chemed has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CHE.

Revenue growth5.2% · median 16.8%

Gross margin33.5% · median 19.1%

Operating margin13.9% · median 5.9%

Net margin10.6% · median 3.7%

Advertisement
300 × 250

See a number that looks wrong?